Transmembrane protein 25 abrogates monomeric EGFR-driven STAT3 activation in triple-negative breast cancer.
Saved in:
| Title: | Transmembrane protein 25 abrogates monomeric EGFR-driven STAT3 activation in triple-negative breast cancer. |
|---|---|
| Authors: | Mohan CD; FEST Division CSIR-Indian Institute of Toxicology Research Lucknow Uttar Pradesh India., Rangappa KS; Institution of Excellence, Vijnana Bhavan University of Mysore Mysore Karnataka India., Sethi G; Department of Pharmacology Yong Loo Lin School of Medicine National University of Singapore Singapore Singapore. |
| Source: | MedComm [MedComm (2020)] 2024 Mar 26; Vol. 5 (4), pp. e492. Date of Electronic Publication: 2024 Mar 26 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: John Wiley & Sons, Inc Country of Publication: China NLM ID: 101769925 Publication Model: eCollection Cited Medium: Internet ISSN: 2688-2663 (Electronic) Linking ISSN: 26882663 NLM ISO Abbreviation: MedComm (2020) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2688-2663 |
|---|---|
| DOI: | 10.1002/mco2.492 |
